- A dictionary of medical eponyms

David Gitlin

Born  1923
Died  2010

Related eponyms

American paediatrician, Born 1921, Bronx, New York; died January 4, 2010, Islamorada, Florida.

Biography of David Gitlin

We thank UPMC/University of Pittsburgh Schools of the Health Sciences for permission to use this article, which we found on their website:

David Gitlin, Pediatrician and Pioneer in Protein Chemistry, Dies at 88.

PITTSBURGH, Jan. 28, 2010 – David Gitlin, M.D., a pediatrician and immunochemistry pioneer whose work led to the discovery of inherited causes of severe infections as well as a biomarker of fetal birth defects that is still in use, died Jan. 4 in Islamorada, Fla., of gastrointestinal cancer. He was 88.

Dr. Gitlin devoted most of his career to studying and treating children with inherited gene alterations that made them highly susceptible to infection, now called immunodeficiency diseases. He combined his knowledge of biology, protein chemistry and medicine to develop new techniques in pediatric research studies.¨

In 1963, Dr. Gitlin joined the University of Pittsburgh School of Medicine as a professor of pediatrics, and he held the title of emeritus professor at the time of his death. He was a member of the Pittsburgh Pediatric Society, and from 1971-73 served as chair of its postgraduate education committee.
“During his illustrious career, Dr. Gitlin made invaluable contributions to further the developing field of immunochemistry,” said Arthur S. Levine, M.D., senior vice chancellor for the health sciences and dean, School of Medicine, University of Pittsburgh. “In fact, I have known of and admired his work since I was a medical student.”

While working at Harvard Medical School, Dr. Gitlin and Charles A. Janeway, M.D., described in 1953 the syndrome of agammaglobulinemia, an inherited disorder in which affected children are susceptible to repeated, serious infections because their bodies can’t produce enough immunoglubulins to fend off bacteria and viruses. Their work explained for the first time in modern biological terms the relationship of specific plasma proteins to infection resistance, and ultimately led to the development of gamma globulin replacement therapy that is used today in thousands of children. Their research also explored the transfer of immunoglobulins from mother to developing fetus, helping to define the factors critical for normal immune defenses in the human infant.

Dr. Gitlin’s other studies described plasma protein metabolism in children with kidney disease, unraveled the process of intestinal iron absorption, and identified ceruloplasmin deficiency as a marker for Wilson’s disease. His protein synthesis work identified alpha fetoprotein as a critical indicator of potentially life-threatening birth defects in the developing baby. For these efforts, he received the Medal of the University of Helsinki in 1967 and became the first recipient, in 1968, of the Federico Gomez Award from the Hospital Infantil de Mexico, Mexico City.

His other awards include the 1956 E. Mead Johnson Award from the Society for Pediatric Research, where he served on the executive council from 1961 to 1963, and the 1963 Borden Award for Pediatric Research from the American Academy of Pediatrics. Dr. Gitlin also was a member of the American Pediatric Society, the American Society for Clinical Investigation and the American Association of Immunologists.

Dr. Gitlin was born in 1921 in the Bronx, attended Stuyvesant High School and was a 1942 Phi Beta Kappa alumnus of the College of the City of New York, where he was a Naumberg scholar. He received his medical degree in 1947 from the New York University School of Medicine and, in 1976, was awarded the school’s Solomon A. Berson medical alumni achievement award.

Following an internship at Morrisania City Hospital in the Bronx, he completed residency and research fellowships at Boston Children’s Hospital and then joined the faculty at Harvard Medical School where he conducted basic and clinical investigation. In 1958, he received a fellowship from the John Simon Guggenheim Memorial Foundation to work with A.S. McFarlane at Mill Hill, London, to develop techniques to trace label proteins that are still in clinical use.

In 1944 he married Geraldine Mary Wadsworth, who died in 2008. His daughter, Susan, died in 2008. He is survived by his son Jonathan, a pediatrician in Nashville, Tenn., and three grandchildren, Joshua, Zachary and Anna.

For the website of UPMC/University of Pittsburgh Schools of the Health Sciences, see: http://www.upmc.com/MediaRelations/NewsReleases/2010/Pages/Gitlin-Dies.aspx


  • David Gitlin:
    Use of Ultraviolet Absorption Spectroscopy in the Quantitative Precipitin Reaction.
    The Journal of Immunology, August 1, 1949. 62 (4): 437-451.
  • David Gitlin, Charles S. Davidson, and Leslie H. Wetterlow:
    The Quantitative Estimation of Serum Albumin in Human Body Fluids by Direct Titration with Specific Horse Antiserum.
    The Journal of Immunology, 1949, 63: 415-425.
  • David Gitlin and Harold Edelhoch:
    A Study of the Reaction between Human Serum Albumin and its Homologous Equine Antibody through the Medium of Light Scattering.
    The Journal of Immunology, 1951, 66: 67-77.
  • David Gitlin, Harrison Latta, William H. Batchelor, Charles A. Janeway, Margaret Cushman, and Katherine Marx:
    Experimental Hypersensitivity in the Rabbit: Disappearance Rates of Native and Labelled Heterologous Proteins from the Serum after Intravenous Injection.
    The Journal of Immunology, 1951, 66: 451-461.
  • David Gitlin and Charles A. Janeway.
    Studies on the Plasma Proteins in the Interstitial Fluid of Muscle.
    Science, September 17, 1954, 120 (3116): 461-463.
  • David Gitlin and Charles A. Janeway.
    Congenital abnormalities in protein synthesis. Pediatrics, June 1958, 21 (6): 1034-1038.
  • David Gitlin, Fernando Mönckeberg, and Charles A. Janeway:
    Effects of Pneumococcus Capsular Polysaccharides on the Degradation of Rabbit Antibodies in Mice. The Journal of Immunology, 1961, 86: 627-634.
  • D. Gitlin and M. Boesman:
    Serum alpha-fetoprotein, albumin, and gamma-G-globulin in the human conceptus.
    The Journal of Clinical Investigation, November 1966, 45 (11): 1826–1838.

What is an eponym?

An eponym is a word derived from the name of a person, whether real or fictional. A medical eponym is thus any word related to medicine, whose name is derived from a person.

What is Whonamedit?

Whonamedit.com is a biographical dictionary of medical eponyms. It is our ambition to present a complete survey of all medical phenomena named for a person, with a biography of that person.


Whonamedit? does not give medical advice.
This survey of medical eponyms and the persons behind them is meant as a general interest site only. No information found here must under any circumstances be used for medical purposes, diagnostically, therapeutically or otherwise. If you, or anybody close to you, is affected, or believe to be affected, by any condition mentioned here: see a doctor.